Income Taxes (Details) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Sep. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Dec. 31, 2024 |
|
| Income Taxes [Line Items] | |||||
| Net deferred tax liability | $ 900,000 | $ 900,000 | |||
| Provision for income taxes | 307,456 | 307,456 | $ 69,400,000 | ||
| Net deferred tax asset | 0 | 0 | 77,500,000 | ||
| Valuation allowance | $ 77,500,000 | $ 77,500,000 | |||
| Minimum [Member] | |||||
| Income Taxes [Line Items] | |||||
| Amount of federal NOLs | 1,000,000 | ||||
| Federal rate | 73,000,000 | ||||
| Amount of state NOLs | 49,000,000 | ||||
| Federal research and development | 0 | ||||
| Maximum [Member] | |||||
| Income Taxes [Line Items] | |||||
| Amount of federal NOLs | 15,000,000 | ||||
| Federal rate | 59,000,000 | ||||
| Amount of state NOLs | 93,000,000 | ||||
| Federal research and development | 752,000 | ||||
| Israeli [Member] | |||||
| Income Taxes [Line Items] | |||||
| Estimated annual effective tax rate | 24.00% | ||||
| Israeli [Member] | Minimum [Member] | |||||
| Income Taxes [Line Items] | |||||
| Israeli NOL’s | 134,000,000 | ||||
| Israeli [Member] | Maximum [Member] | |||||
| Income Taxes [Line Items] | |||||
| Israeli NOL’s | $ 127,000,000 | ||||
| X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible foreign operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences from research and development costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the income tax rates. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|